Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mathias Lichterfeld, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Mathias Lichterfeld and Rajesh Gandhi.
Connection Strength

0.472
  1. Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir. Open Forum Infect Dis. 2015 Apr; 2(2):ofv045.
    View in: PubMed
    Score: 0.160
  2. Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. . 2012 Jan 01; 59(1):1-9.
    View in: PubMed
    Score: 0.128
  3. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007 Nov 26; 204(12):2813-24.
    View in: PubMed
    Score: 0.096
  4. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018 08 31; 128(9):4074-4085.
    View in: PubMed
    Score: 0.051
  5. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination. J Virol. 2014 Aug; 88(15):8349-54.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.